A novel coronavirus vaccine trial in the US has now given a dose to its first participant, the National Institute of Allergy and Infectious Diseases announced Monday. https://t.co/T9CENcKm2X— CNN (@CNN) March 17, 2020
Tuesday, March 17, 2020
A novel coronavirus vaccine trial in the US has now given a dose to its first participant, the National Institute of Allergy and Infectious Diseases announced Monday.
